Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2676250 | Seminars in Oncology Nursing | 2014 | 7 Pages |
ObjectivesTo provide an overview of emerging applications for and challenges associated with biospecimen collection for evaluating personalized disease risk and/or treatment response in cancer clinical trials.Data SourcesPublished nursing and medical literature.ConclusionBlood- and tissue-based biomarkers are increasingly utilized to identify the molecular signatures of disease that can inform the determination of a course of treatment in a very precise manner. There are challenges for the oncology nurse related to specimen collection, processing, analysis, and translation to precision treatment.Implications for Nursing PracticeIt is important for nurses to have appropriate training and a working understanding of the procedures for biospecimen collection and how biospecimen analyses can inform precision assessment of risk and prognosis.